Skip to main content
Clinical Trials/JPRN-UMIN000010085
JPRN-UMIN000010085
Recruiting
未知

A prospective multicenter study of patients treated with molecular target therapy for hepatocellular carcinoma - Molecular target therapy for hepatocellular carcinoma: a prospective multicenter study

Osaka University Graduate School of Medicine, Department of Gastroenterology and Hepatology0 sites300 target enrollmentMarch 1, 2013

Overview

Phase
未知
Intervention
Not specified
Conditions
Hepatocellular carcinoma
Sponsor
Osaka University Graduate School of Medicine, Department of Gastroenterology and Hepatology
Enrollment
300
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
March 1, 2013
End Date
December 15, 2022
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Osaka University Graduate School of Medicine, Department of Gastroenterology and Hepatology

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • (1\) Patients who do not give informed consent (2\) Patients who is not thought to be eligible for participation in this study by researchers

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
A multicentre, prospective clinical study analysing outcomes of shoulder arthroplasty with SMR STEMLESSosteoarthritis of the shouldercuff tear arthropathy1002321310005944
NL-OMON47760AMSA50
Completed
Phase 4
To study the safety and efficacy of Ranibizumab of Intas Pharmaceuticals Ltd. in patients with visual impairment.Health Condition 1: H353- Degeneration of macula and posterior pole
CTRI/2016/03/006739Intas Pharmaceuticals Ltd126
Completed
Not Applicable
A prospective multicenter cohort study for treatment outcome, QOL, cost and cost-effectiveness of R-CHOP therapy alone and radiation combination therapy in untreated adult primary diffuse large B-cell lymphoma.ntreated limited-stage DLBC
JPRN-UMIN000026684Clinical Hematology Study Group of National Hospital Organization100
Active, not recruiting
Phase 1
A multi-centre clinical trial evaluating patients’ ability to independently and safely use the medicinal product indicated in the treatment of erectile dysfunctioErectile dysfunctionMedDRA version: 20.0 Level: LLT Classification code 10052003 Term: Erectile dysfunction NOS System Organ Class: 100000004872Therapeutic area: Diseases [C] - Male diseases of the urinary and reproductive systems [C12]
EUCTR2018-002597-41-PLAdamed Pharma S.A.400
Active, not recruiting
Phase 1
A study comparing the effect of chemotherapy with the effect of chemotherapy plus local removal of metastases for patients with cancer of the large bowel which has spread to multiple organs.multi-organ metastatic colorectal cancerMedDRA version: 21.0Level: LLTClassification code 10052362Term: Metastatic colorectal cancerSystem Organ Class: 100000004864Therapeutic area: Diseases [C] - Cancer [C04]
EUCTR2011-005003-32-NLVU University Medical Center, Department of Medical Oncology478